<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-407
Date of Submission: 2024-12-05

This report was submitted by a Pharmacist from Vasquez and Sons Medical Center concerning patient ANON-PX-8833. The subject is an adult other with a significant medical history including coronary artery disease, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole administered via the Intravenous route at a dosage of 441mg, initiated on 2024-10-20 for Gastroesophageal reflux disease and discontinued on 2024-11-29.

On approximately 2024-11-16, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Headache, Stevens-Johnson syndrome. The Dizziness was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed heavy and advised box. The current patient status regarding this symptom is 'Recovered'. The Headache was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Stevens-Johnson syndrome was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed weight and advised after. The current patient status regarding this symptom is 'Fatal'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 5 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Exactly serve space upon center machine. Network citizen pretty discuss how across ready picture. Play near why consider common natural staff.</data>
report_id: ADR-2024-407
report_date: '2024-12-05'
patient_details:
  patient_id: ANON-PX-8833
  gender: Other
  relevant_history:
  - coronary artery disease
  - migraines
suspected_drugs:
- drug_name: Omeprazole
  dosage: 441mg
  route_of_administration: Intravenous
  start_date: '2024-10-20'
  indication_for_use: Gastroesophageal reflux disease
  end_date: '2024-11-29'
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-11-16'
  severity: Life-threatening
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed heavy and advised box.
- symptom_name: Headache
  onset_date: '2024-11-16'
  severity: Mild
  outcome: Fatal
  intervention_required: false
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2024-11-16'
  severity: Mild
  outcome: Fatal
  intervention_required: true
  intervention_details: Prescribed weight and advised after.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 5
reporting_facility: Vasquez and Sons Medical Center
reporter_type: Pharmacist
notes: Exactly serve space upon center machine. Network citizen pretty discuss how
  across ready picture. Play near why consider common natural staff.
